Literature DB >> 20118813

Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature.

Jorge Garbino1, Catherine Myers, Juan Ambrosioni, Fabienne Gumy-Pause.   

Abstract

Zygomycosis is an emerging, opportunistic fungal infection particularly affecting immunocomprised patients. We report the case of a 10-year-old girl who developed pulmonary zygomycosis because of Cunninghamella bertholletiae 1 year after undergoing bone marrow transplantation complicated with severe cutaneous and digestive graft-versus-host disease. Treatment with surgery and liposomal amphotericin B followed by posaconazole successfully treated the infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20118813     DOI: 10.1097/MPH.0b013e3181c2bdce

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  8 in total

Review 1.  Cunninghamella bertholletiae Infection in a HLA-Haploidentical Hematopoietic Stem Cell Transplant Recipient with Graft Failure: Case Report and Review of the Literature.

Authors:  Chao Luo; Jiasheng Wang; Yongxian Hu; Yi Luo; Yamin Tan; Aiyun Jin; Bin Wei; Huixian Hu; He Huang
Journal:  Mycopathologia       Date:  2016-06-28       Impact factor: 2.574

Review 2.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.

Authors:  F Javier Pastor; Mery Ruíz-Cendoya; Isabel Pujol; Emilio Mayayo; Deanna A Sutton; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2010-08-30       Impact factor: 5.191

Review 4.  [Clinical features of children with Cunninghamella spp. infection: a case report and literature review].

Authors:  F Wu; J Tian; Z She; Y Liu; W Wan; C Wen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-05-20

Review 5.  Disseminated zygomycosis caused by Cunninghamella bertholletiae in patient with hematological malignancy and review of published case reports.

Authors:  Tsung-Ting Hsieh; Hsiang-Kuang Tseng; Pei-Lun Sun; Yu-Hung Wu; Gon-Shen Chen
Journal:  Mycopathologia       Date:  2012-11-04       Impact factor: 2.574

6.  Successful Treatment of Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae with High-Dose Liposomal Amphotericin B (10 mg/kg/day) Followed by a Lobectomy in Cord Blood Transplant Recipients.

Authors:  Hikari Ota; Hisashi Yamamoto; Muneyoshi Kimura; Hideki Araoka; Takeshi Fujii; Takashi Umeyama; Hideaki Ohno; Yoshitsugu Miyazaki; Daisuke Kaji; Yuki Taya; Aya Nishida; Kazuya Ishiwata; Masanori Tsuji; Shinsuke Takagi; Yuki Asano-Mori; Go Yamamoto; Naoyuki Uchida; Koji Izutsu; Kazuhiro Masuoka; Atsushi Wake; Akiko Yoneyama; Shigeyoshi Makino; Shuichi Taniguchi
Journal:  Mycopathologia       Date:  2017-06-02       Impact factor: 2.574

7.  Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome.

Authors:  Jun Feng; Xuefeng Sun
Journal:  Infection       Date:  2018-05-10       Impact factor: 3.553

Review 8.  Biology, systematics, and clinical manifestations of Zygomycota infections.

Authors:  A Muszewska; J Pawłowska; P Krzyściak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-11       Impact factor: 3.267

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.